Skip to main content

Table 1 Baseline characteristics of the IFNα1b group and the control group (FAS)

From: Efficacy and safety of aerosol inhalation of recombinant human interferon α1b (IFNα1b) injection for noninfluenza viral pneumonia, a multicenter, randomized, double-blind, placebo-controlled trial

 IFNα1b GroupControl GroupP
7687
SexFemale21 (27.6%)47 (54.0%)0.001
Male55 (72.4%)40 (46.0%) 
Age 55.230 ± 18.95051.860 ± 19.5280.268
BMI 24.306 ± 3.03423.814 ± 3.1790.380
Time of onset (days) 5.3 ± 4.24.7 ± 2.70.239